Efficacy and safety of sacubitril/valsartan in heart failure compared to renin-angiotensin-aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials.
Journal Information
Full Title: Arch Med Sci
Abbreviation: Arch Med Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, General & Internal
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest M.B. has received research grants/support from Amgen, Mylan/Viatris, Sanofi, and Valeant, and he has served as a consultant/received speakers fee from Amgen, Daiichi-Sankyo, Esperion, Freia Pharmaceuticals, Herbapol, Kogen, KRKA, Mylan/Viatris, Novartis, Novo-Nordisk, Polfarmex, Polpharma, Sanofi-Aventis, Servier, Teva, and Zentiva. He is CMO at the Nomi Biotech Corporation Ltd. A.M.B.-D. has given lectures that were sponsored by Novartis Polska Sp.z o. o. The remaining authors do not have any competing interests to disclose."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025